Virtual Therapeutics, Akili Interactive (AKLI) Enter Into Definitive Merger Agreement

Go back to Virtual Therapeutics, Akili Interactive (AKLI) Enter Into Definitive Merger Agreement

Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company

May 29, 2024 8:00 AM UTC

Akili to operate as wholly owned subsidiary of Virtual Therapeutics

KIRKLAND, Wash. & BOSTON--(BUSINESS WIRE)-- Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced the signing of a definitive merger agreement to form a diversified, leading digital health company.

Under the terms of the agreement, Akili shareholders will receive $0.4340 per share of common stock in cash. The per share purchase price represents an approximately 4% premium to Akilis closing stock... More